ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

0RGI Cosmo Pharmaceuticals Nv

126.90
0.00 (0.00%)
Last Updated: 10:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2022 20152016201720182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 60.61M67.66M66.44M64.67M63.25M66.8M65.89M103.99M
Operating Income -16.06M21.01M-15.5M-22.07M-17.37M1.96M28.3M28.06M
Pre Tax Income 254.29M27.49M-32.43M-17.46M-21.3M-6.93M24M24.47M
Net Income 248.19M19.34M-32.45M-18.11M-24.42M-7.9M21.67M17.23M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 17.2141.371-0.9-0.502-0.677-0.2190.6010.321
EBIT 250.3M21.01M-15.5M-22.07M-17.37M1.96M28.3M28.06M
EBITDA -7.57M24.05M-11.96M-17.59M-11.62M8M37.94M41.91M

Your Recent History

Delayed Upgrade Clock